Adjustment of the ACEF score by the triglyceride glucose index improves the prediction of clinical outcomes in patients undergoing percutaneous coronary intervention

Cardiovasc DiabetolPublished Observational cohort study

Authors' conclusion

The combination of the TyG index and the ACEF score enhances the predictive ability for long-term MACCEs in patients with CHD undergoing PCI.

Study context

Population
Patients with CHD who underwent PCI at the Third People's Hospital of Chengdu, China, May 2018–December 2022
Participants
1,248 patients
Exposure
High vs low ACEF score and triglyceride-glucose (TyG) index; ACEF + TyG added to conventional risk model
Outcome
MACCEs
Follow-up
Median 30.60 months
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

Hazard ratio (95% CI)P value
ACEF >1.27Kaplan-Meier;vs lower ACEF
2.018(1.593–2.789)
Log-Rank test, P < 0.001
TyG >8.82Kaplan-Meier;vs lower TyG
2.057(1.572–2.691)
Log-Rank test, P < 0.001
ACEF scoremultivariable Cox
1.702(1.210–2.394)
P = 0.002
TyG indexmultivariable Cox
1.575(1.296–1.916)
P < 0.001
Patients with major adverse cardiac and cerebrovascular events (MACCEs)
214

Observational data: associations, not effects.

Further findings

Incremental prediction of MACCEs: ACEF + TyG added to conventional risk model

C-statistic
0.664 to 0.703
Continuous net reclassification improvement (NRI)
0.391
Categorical NRI
0.107
Integrated discrimination improvement (IDI)
0.033
P (all)
P < 0.001

Original publication

Adjustment of the ACEF score by the triglyceride glucose index improves the prediction of clinical outcomes in patients undergoing percutaneous coronary intervention. Cardiovasc Diabetol. Published 18 December 2024. doi:10.1186/s12933-024-02534-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.